Bringing the woolly mammoth back to life is no easy task. But for Ben Lamm, CEO of Colossal Biosciences, the stress of the ...

A while back, Thomas Tull, billionaire Hollywood mogul turned venture capitalist, invited a group of friends to a rodeo in ...

Colossal Biosciences, a Texas-based company, genetically engineered a woolly mouse, marking an achievement toward its goal of ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an eye-popping $10.2 billion valuation. But it has yet to be paid for reviving extinct ...

It's not quite Jurassic Park, but so far, this is perhaps the closest humans have come yet to making the plot of that film a reality. This comes as Colossal Biosciences has reached a major ...

Colossal Biosciences genetically engineered a ‘woolly mouse’ with mammoth traits. The milestone could inform human gene therapy.

US biotechnology company Colossal Laboratories and Biosciences has a radical proposal: it wants to resurrect the woolly ...

Better to safeguard our existing animals and the Earth than resurrect extinct species or flee to another planet.

Since Colossal Biosciences launched in 2021, it’s skyrocketed to a $10.2 billion valuation to fund its mission of de-extinction. For Colossal, it’s more than the buzzy headlines that its ...

We all watch movies like Jurassic Park and Jurassic World and marvel at the possibilities of bringing back animals and ...